Nautilus Group (NYSE: NLS) and USANA Health Sciences (NYSE:USNA) are both small-cap retail/wholesale companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends and valuation.
Risk & Volatility
Nautilus Group has a beta of 2.12, meaning that its share price is 112% more volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500.
This table compares Nautilus Group and USANA Health Sciences’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Nautilus Group||$406.04 million||1.04||$34.17 million||$0.95||14.42|
|USANA Health Sciences||$1.01 billion||1.69||$100.04 million||$3.63||19.50|
USANA Health Sciences has higher revenue and earnings than Nautilus Group. Nautilus Group is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.
This table compares Nautilus Group and USANA Health Sciences’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|USANA Health Sciences||8.79%||26.38%||19.20%|
Institutional and Insider Ownership
97.9% of Nautilus Group shares are held by institutional investors. Comparatively, 43.8% of USANA Health Sciences shares are held by institutional investors. 3.7% of Nautilus Group shares are held by company insiders. Comparatively, 53.2% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
This is a breakdown of recent ratings and price targets for Nautilus Group and USANA Health Sciences, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|USANA Health Sciences||0||0||1||0||3.00|
Nautilus Group presently has a consensus target price of $18.96, indicating a potential upside of 38.43%. USANA Health Sciences has a consensus target price of $80.00, indicating a potential upside of 12.99%. Given Nautilus Group’s higher probable upside, equities research analysts plainly believe Nautilus Group is more favorable than USANA Health Sciences.
USANA Health Sciences beats Nautilus Group on 10 of the 14 factors compared between the two stocks.
About Nautilus Group
Nautilus, Inc. is a consumer fitness products company. The Company operates through two segments: Direct and Retail. Its principal business activities include designing, developing, sourcing and marketing of cardio and strength fitness products and related accessories for consumer use, primarily in the United States and Canada, but also in international markets outside North America. The Direct business offers products directly to consumers through television advertising, catalogs and the Internet. In its Direct business, the Company markets and sells its products, principally Bowflex cardio and strength products, directly to consumers. The Retail business offers its products through a network of independent retail companies and specialty retailers with stores and Websites located in the United States and internationally. In its Retail business, the Company markets and sells a line of consumer fitness equipment under the Nautilus, Octane Fitness, Schwinn, Universal and Bowflex brands.
About USANA Health Sciences
USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.
Receive News & Ratings for Nautilus Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nautilus Group and related companies with MarketBeat.com's FREE daily email newsletter.